Phage Therapy: A Targeted Solution for Brucellosis
Vector-Borne and Zoonotic Diseases · 2025-12 · 25 (12) · 713-721
DOI: 10.1177/15303667251367519 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vector-Borne and Zoonotic Diseases, online erschienen am 16.01.2026. Verfasst von Bahareh Lashtoo Aghaee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Assistant Professor of Bacteriology, Ramsar Campus, Mazandaran University of Medical Sciences, Ramsar, Iran. Hauptthemen laut MEDLINE: Phage Therapy, Brucellosis, Bacteriophages, Brucella. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
Background
Brucellosis is a widespread zoonotic bacterial infection that affects over 500,000 people annually, with significant economic losses in the livestock industry, particularly in endemic regions such as the Middle East, Asia, and parts of Africa and Latin America. Despite standard antibiotic treatments, relapse rates remain as high as 10%–15%, highlighting the limitations of current therapeutic options.
Objective
Phage therapy, which uses bacteriophages to selectively target and lyse Brucella spp. bacteria, offers a promising approach for managing brucellosis.
Methods
This paper explores the current understanding of brucellosis, highlighting the impact on animal and human health, and reviews the mechanisms and efficacy of bacteriophages against Brucella spp.Results:Key factors, such as phage specificity, immune modulation, and recent advancements in phage encapsulation, are discussed as strategies to enhance treatment efficacy.
Conclusion
This review aims to explore emerging alternative therapies beyond conventional antibiotics, focusing on approaches such as immunotherapy, bacteriophage therapy, and novel vaccine strategies to improve clinical outcomes and reduce disease burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Assistant Professor of Bacteriology, Ramsar Campus, Mazandaran University of Medical Sciences, Ramsar, Iran.
- Infectious Disease Research Center, Avicenna Institute of Clinical Sciences, Avicenna Health Research Institute, Hamadan University of Medical Sciences, Hamadan, Iran.
- Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
- Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, Iran.
- Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
- Picturs Consultancy Molecular Microbiology, emeritus professor Innovative Molecular Diagnostics, University of Leiden, The Netherlands.
Zitieren
APA
Lashtoo Aghaee, B., Alikhani, M. Y., Kazemi, S., Ahmadyousefi, M., van Leeuwen, W. B., & Nasaj, M. (2025). Phage Therapy: A Targeted Solution for Brucellosis. Vector-Borne and Zoonotic Diseases, 25(12), 713-721. https://doi.org/10.1177/15303667251367519
Vancouver
Lashtoo Aghaee B, Alikhani MY, Kazemi S, Ahmadyousefi M, van Leeuwen WB, Nasaj M. Phage Therapy: A Targeted Solution for Brucellosis. Vector-Borne and Zoonotic Diseases. 2025;25(12):713-721. doi:10.1177/15303667251367519
BibTeX
@article{LashtooAghaee2025,
author = {Lashtoo Aghaee, Bahareh and Alikhani, Mohammad Yousef and Kazemi, Sima and Ahmadyousefi, Mohammad and van Leeuwen, Willem B and Nasaj, Mona},
title = {Phage Therapy: A Targeted Solution for Brucellosis},
journal = {Vector-Borne and Zoonotic Diseases},
year = {2025},
volume = {25},
number = {12},
pages = {713--721},
doi = {10.1177/15303667251367519}
}
EUVIMED